What is Tyra Biosciences, Inc.'s R&D?

Tyra Biosciences, Inc. (TYRA) reported R&D of $33.47M in Q1 2026.

How has Tyra Biosciences, Inc.'s R&D changed year-over-year?

Tyra Biosciences, Inc.'s R&D increased by 34.1% year-over-year, from $24.96M to $33.47M.

What is the long-term trend for Tyra Biosciences, Inc.'s R&D?

Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s R&D has grown at a 49.4% compound annual growth rate (CAGR), from $20.64M to $102.93M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Tyra Biosciences, Inc. TYRA R&D

R&D at other companies

IncyteINCY

$515.9M+18.0%

BioMarin PharmaceuticalsBMRN

$178.8M+12.6%

BridgeBio PharmaBBIO

$126.64M+13.6%

ArriVent BioPharma, Inc.AVBP

$37.62M-38.6%

Syndax PharmaceuticalsSNDX

$58.85M-4.5%

Viridian Therapeutics, Inc.VRDN

$77.63M+1.0%

Segments

By segment

See full

Personnel Costs$11.79M+46.9%

IRNMIBC$5.25M+307%

ACH$4.31M+20.1%

FGFR Discovery$2.53M-19.2%

LGUTUC$2.44M—

Facilities And Other Costs$1.63M+16.3%

Other financials

Income statement

See full

Operating income-$42.0M-31.9%

Net income-$39.3M-39.6%

EPS (diluted)-$0.64-36.2%

Balance sheet

See full

Cash & equivalents$85.0M-15.7%

Total debt$5.7M-6.9%

Total equity$387.6M+19.8%

Total assets$412.0M+20.0%

Cash flow

See full

Operating cash flow-$32.6M-27.9%

CapEx$88.0K+529%

Free cash flow-$32.7M-28.2%

Valuation

See full

Market cap$1.81B+318%

Enterprise value$1.73B+397%

Returns & leverage

See full

Return on equity-36.9%+21.1pp

Debt / equity0×0.0×

Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s R&D?: Tyra Biosciences, Inc. (TYRA) reported R&D of $33.47M in Q1 2026.
How has Tyra Biosciences, Inc.'s R&D changed year-over-year?: Tyra Biosciences, Inc.'s R&D increased by 34.1% year-over-year, from $24.96M to $33.47M.
What is the long-term trend for Tyra Biosciences, Inc.'s R&D?: Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s R&D has grown at a 49.4% compound annual growth rate (CAGR), from $20.64M to $102.93M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.